Activities of enzymes that hydrolyze adenine nucleotides in lymphocytes from patients with rheumatoid arthritis

Cell Biochemistry and Function

Volumn 31, Issue 5, 2013, Pages 395-399

  dos Santos Jaques, Jeandre Augusto ^a   Becker, Lara Vargas ^a   Souza, Viviane do Carmo Gonçalves ^a   Leal, Cláudio Alberto Martins ^a   Bertoldo, Tatiana Montagner Dalcin ^a   de Vargas Pinheiro, Kelly ^a   Morsch, Vera Maria ^a   Schetinger, Maria Rosa Chitolina ^a   Leal, Daniela Bitencourt Rosa ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

E ADA; E NTPDase; Lymphocytes; Nucleotides; Rheumatoid arthritis

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; NUCLEOSIDE TRIPHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOMODULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

E-ADA; E-NTPDASE; LYMPHOCYTES; NUCLEOTIDES; RHEUMATOID ARTHRITIS;

ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADULT; ANTIGENS, CD; APYRASE; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELLS, CULTURED; ENZYME ASSAYS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 84879844192     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2910     Document Type: Article

References (39)

1. Kamanli A, Naziroglu M, Aydilek N, Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 2004; 22: 53-57.
2. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
3. Saxne T, Palladino MA, Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31: 1041-1045.
4. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G. Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982; 2: 49-53.
5. Di Giovine FS, Nuki G, Duff GW. Tumour necrosis factor in synovial exudates. Ann Rheum Dis 1988; 47: 768-772.
6. Hopkins SJ, Humphreys M, Jayson MI. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988; 72: 422-427.
7. Hopkins SJ, Meager A. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988; 73: 88-92.
8. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004; 240: 31-304.
9. Ralevic V, Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 2003; 16: 133-140.
10. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006; 112: 358-404.
11. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 2001; 52: 44-56.
12. Franco R, Casado V, Ciruela F, et al. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 1997; 52: 283-294.
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
14. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97: 77-89.
15. Jaques JA, Peres Rezer JF, Ruchel JB, et al. A method for isolation of rat lymphocyte-rich mononuclear cells from lung tissue useful for determination of nucleoside triphosphate diphosphohydrolase activity. Anal Biochem 2011; 410: 34-39.
16. Leal DB, Streher CA, Bertoncheli CM, et al. HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim Biophys Acta 2005; 1746: 129-134.
17. Chan KM, Delfert D, Junger KD. A direct colorimetric assay for Ca2+ -stimulated ATPase activity. Anal Biochem 1986; 157: 375-380.
18. Guisti G, Galanti B. Methods of enzymatic analysis. VerlagChemie: Weinheim, 1984; 315-323.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
20. Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010; 62: 383-391.
21. Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-2126.
22. Jaques JAS, Rezer JFP, Ruchel JB, et al. Lung and blood lymphocytes NTPDase and acetylcholinesterase activity in cigarette smoke-exposed rats treated with curcumin. Biomed Prev Nutr 2011; 1: 109-115.
23. Jaques JA, Ruchel JB, Schlemmer KB, et al. Effects of curcumin on the activities of the enzymes that hydrolyse adenine nucleotides in platelets from cigarette smoke-exposed rats. Cell Biochem Funct 2011; 29: 630-635.
24. Saucedo EM, Pereira RS, Barbosa GM, et al. Enzymes that hydrolyze adenine nucleotides in lymphocytes and platelets of immunosuppressed rats. Biomed Pharmacother 2010; 64: 437-440.
25. Loza MJ, Shane Anderson A, O'Rourke KS, Wood J, Khan IU. T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus. Cell Immunol 2011.
26. Becker LV, Rosa CS, Souza VC, et al. Activities of enzymes that hydrolyze adenine nucleotides in platelets from patients with rheumatoid arthritis. Clin Biochem 2010; 43: 1096-1100.
27. Nakamachi Y, Koshiba M, Nakazawa T, et al. Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts. Arthritis Rheum 2003; 48: 668-674.
28. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-442.
29. Forrest CM, Harman G, McMillan RB, Stoy N, Stone TW, Darlington LG. Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 89-92.
30. Varani K, Padovan M, Govoni M, Vincenzi F, Trotta F, Borea PA. The role of adenosine receptors in rheumatoid arthritis. Autoimmun Rev 2010; 10: 61-64.
31. Varani K, Massara A, Vincenzi F, et al. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Arthritis Rheum 2009; 60: 2880-2891.
32. Varani K, Padovan M, Vincenzi F, et al. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release. Arthritis Res Ther 2011; 13: R197.
33. Di Virgilio F, Boeynaems JM, Robson SC. Extracellular nucleotides as negative modulators of immunity. Curr Opin Pharmacol 2009; 9: 507-513.
34. Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 2003; 48: 594-601.
35. Spanevello RM, Mazzanti CM, Schmatz R, et al. The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients. Clin Chim Acta 2010; 411: 210-214.
36. Schmatz R, Schetinger MR, Spanevello RM, et al. Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. Life Sci 2009; 84: 345-350.
37. Borsellino G, Kleinewietfeld M, Di Mitri D, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225-1232.
38. Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257-1265.
39. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007; 13: 108-116.